Multiple myeloma is the second most common malignant hematologic malignancy which evolved different strategies for immune escape from the host immune...

Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with specific genomic, transcriptional and...

To assess the prognostic value of C-Reactive Protein (CRP), at diagnosis and during follow-up, of patients with Hodgkin’s Lymphoma treated at the...

Linear IgA bullous dermatosis in association with nodal peripheral T cell lymphoma with a T follicular helper phenotype and multiple myeloma: a case...

Preventive versus curative photobiomodulation for oral mucositis in patients with multiple myeloma undergoing hematopoietic stem cell transplantation...

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a distinct subtype of T-cell non-Hodgkin lymphoma that arises in the context of...

Severe and continuous immunoparesis during induction or maintenance therapy in nontransplant patients with multiple myeloma is a sign of poor...

Laboratory reflex testing strategy for the early identification of primary care patients with multiple myeloma.

Research progress of the chemokine/chemokine receptor axes in the oncobiology of multiple myeloma (MM).

Sarcopenia does not impact the outcome of patients with Multiple Mieloma consolidated with autologous Hematopoietic Stem Cell Transplantation.